Jeff R. Schroeder
Corporate Officer/Principal at Oxford Immunotec Ltd.
Profile
Jeff R.
Schroeder is currently the President-Strategic Account at Oxford Immunotec Ltd.
He previously held positions as the Head-Diagnostics Division at Abbott Laboratories, Vice President-Marketing at Cytyc Corp., Chief Commercial Officer at Oxford Immunotec Global Ltd., and Vice President-Sales & Marketing at Cytologix Corp.
Mr. Schroeder completed his undergraduate degree at Southeast Missouri State University.
Jeff R. Schroeder active positions
Companies | Position | Start |
---|---|---|
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Corporate Officer/Principal | 01/01/2007 |
Former positions of Jeff R. Schroeder
Companies | Position | End |
---|---|---|
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Sales & Marketing | 01/01/2007 |
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Sales & Marketing | 01/01/2002 |
OXFORD IMMUNOTEC GLOBAL PLC | Corporate Officer/Principal | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Training of Jeff R. Schroeder
Southeast Missouri State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 4 |
---|---|
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Commercial Services |
Oxford Immunotec Global Ltd.
Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Global Ltd. operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND. The company was founded by Peter James Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jeff R. Schroeder